Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 2NIH 1INDUSTRY 1

Study Type

Interventional 182Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Ototoxicity 1Central Nervous System Neoplasms 1

Interventions

Amplified Fragment Length Polymorphism Analysis 21Gene Expression Profiling 17Microarray Analysis 13Immunohistochemistry 12Polymerase Chain Reaction 9Specimen Handling 6Psychiatric Rehabilitation 6Reverse Transcriptase Polymerase Chain Reaction 5Mass Spectrometry 4Flow Cytometry 4Biopsy 4Molecular Diagnostic Techniques 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Immunologic Techniques 3Genetic Linkage 3DNA Methylation 3Cytogenetic Analysis 3Chromatography, High Pressure Liquid 3Watchful Waiting 2Therapeutics 2Leukapheresis 2In Situ Hybridization, Fluorescence 2Immunoenzyme Techniques 2Genetic Testing 2Early Intervention, Educational 2Cyclophosphamide 2Carboplatin 2Bleeding Time 2hepatitis B hyperimmune globulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Observational × Vincristine × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡